|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2005-4-26
|
|
pubmed:abstractText |
The purpose of this study was to evaluate the hypothesis that presumed reversion of electrical remodeling after cardioversion of atrial fibrillation (AF) restores the efficacy of flecainide.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1547-5271
|
|
pubmed:author |
pubmed-author:AllessieMaurits AMA,
pubmed-author:BennekersJohan HJH,
pubmed-author:BoskerHans AHA,
pubmed-author:BrackeFrank A L EFA,
pubmed-author:CrijnsHarry J G MHJ,
pubmed-author:HaaksmaJaapJ,
pubmed-author:KingmaTsjerkT,
pubmed-author:KirchhofCharles J H JCJ,
pubmed-author:TielemanRobert GRG,
pubmed-author:Van GelderIsabelle CIC,
pubmed-author:VeegerNic J G MNJ,
pubmed-author:WildeArthur A MAA
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
2
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
223-30
|
|
pubmed:dateRevised |
2009-10-27
|
|
pubmed:meshHeading |
pubmed-meshheading:15851308-Aged,
pubmed-meshheading:15851308-Anti-Arrhythmia Agents,
pubmed-meshheading:15851308-Atrial Fibrillation,
pubmed-meshheading:15851308-Electric Countershock,
pubmed-meshheading:15851308-Female,
pubmed-meshheading:15851308-Flecainide,
pubmed-meshheading:15851308-Humans,
pubmed-meshheading:15851308-Logistic Models,
pubmed-meshheading:15851308-Male,
pubmed-meshheading:15851308-Middle Aged,
pubmed-meshheading:15851308-Multivariate Analysis,
pubmed-meshheading:15851308-Prognosis,
pubmed-meshheading:15851308-Recurrence,
pubmed-meshheading:15851308-Time Factors
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Does flecainide regain its antiarrhythmic activity after electrical cardioversion of persistent atrial fibrillation?
|
|
pubmed:affiliation |
University Hospital Maastricht, The Netherlands. r.tieleman@fys.unimaas.nl
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
